FACE2FACE PARKINSON'S C.I.C.

Company limited by guarantee

Company Registration Number:
12739859 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2024

Period of accounts

Start date: 1 August 2023

End date: 31 July 2024

FACE2FACE PARKINSON'S C.I.C.

Contents of the Financial Statements

for the Period Ended 31 July 2024

Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

FACE2FACE PARKINSON'S C.I.C.

Balance sheet

As at 31 July 2024

Notes 2024 2023


£

£
Fixed assets
Tangible assets: 3 32 63
Total fixed assets: 32 63
Current assets
Cash at bank and in hand: 7,379 959
Total current assets: 7,379 959
Creditors: amounts falling due within one year: 4 ( 425 ) ( 405 )
Net current assets (liabilities): 6,954 554
Total assets less current liabilities: 6,986 617
Total net assets (liabilities): 6,986 617
Members' funds
Profit and loss account: 6,986 617
Total members' funds: 6,986 617

The notes form part of these financial statements

FACE2FACE PARKINSON'S C.I.C.

Balance sheet statements

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 26 March 2025
and signed on behalf of the board by:

Name: K Carter
Status: Director

The notes form part of these financial statements

FACE2FACE PARKINSON'S C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Donations are recognised on receipt.

    Tangible fixed assets depreciation policy

    Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount. Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows: Plant and machinery 25% straight line Impairment - A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

    Other accounting policies

    FINANCIAL INSTRUMENTS A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised. PROFESSIONAL FEES Payment for professional services provided to the CIC by K Carter.

FACE2FACE PARKINSON'S C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 2 2

FACE2FACE PARKINSON'S C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 August 2023 125 125
Additions
Disposals
Revaluations
Transfers
At 31 July 2024 125 125
Depreciation
At 1 August 2023 62 62
Charge for year 31 31
On disposals
Other adjustments
At 31 July 2024 93 93
Net book value
At 31 July 2024 32 32
At 31 July 2023 63 63

FACE2FACE PARKINSON'S C.I.C.

Notes to the Financial Statements

for the Period Ended 31 July 2024

4. Creditors: amounts falling due within one year note

2024 2023
£ £
Taxation and social security 8 0
Other creditors 417 405
Total 425 405

COMMUNITY INTEREST ANNUAL REPORT

FACE2FACE PARKINSON'S C.I.C.

Company Number: 12739859 (England and Wales)

Year Ending: 31 July 2024

Company activities and impact

We provide face-to-face support to anyone who lives with Parkinson’s, MSA, PSP or CBD from diagnosis onwards. This includes education and training to anyone working with Parkinson’s with a particular interest in offering support to care staff and agencies. This helps to reduce the anxiety for someone with Parkinson’s, their relatives, or carers when seeking and selecting home care.

Consultation with stakeholders

The company’s stakeholders are the donees and members found face to face and through the website. We provide a survey on the website, at events and have social media where anyone can comment or message us. At the moment, the only feedback has been positive. If any negative feedback comes, we will act accordingly.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
26 March 2025

And signed on behalf of the board by:
Name: K Carter
Status: Director